These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27194426

  • 1. Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
    Cao X, Nakamura Y, Wada T, Izumi-Nakaseko H, Ando K, Zhu B, Xu B, Takahara A, Saitoh M, Sugiyama A.
    Heart Vessels; 2016 Dec; 31(12):2045-2052. PubMed ID: 27194426
    [Abstract] [Full Text] [Related]

  • 2. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Fujisawa M, Yorikane R, Matsuoka Y, Koike H, Ueno K.
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
    [Abstract] [Full Text] [Related]

  • 3. Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs.
    Takahara A, Iwasaki H, Nakamura Y, Sugiyama A.
    Eur J Pharmacol; 2007 Jun 22; 565(1-3):166-70. PubMed ID: 17445796
    [Abstract] [Full Text] [Related]

  • 4. L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
    Aritomi S, Konda T, Yoshimura M.
    Heart Vessels; 2012 Jul 22; 27(4):419-23. PubMed ID: 21989861
    [Abstract] [Full Text] [Related]

  • 5. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2004 Jun 22; 18(3):309-19. PubMed ID: 15147282
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S, Harada E, Sugino K, Nishimura M, Nakamura T, Takahara A.
    Clin Exp Pharmacol Physiol; 2015 Apr 22; 42(4):344-52. PubMed ID: 25582553
    [Abstract] [Full Text] [Related]

  • 7. N- and L-type calcium channels blocker cilnidipine ameliorates neuropathic pain.
    Yamamoto S, Suzuki Y, Ono H, Kume K, Ohsawa M.
    Eur J Pharmacol; 2016 Dec 15; 793():66-75. PubMed ID: 27823932
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the direct negative dromotropic effect of a new calcium channel blocker, cilnidipine, with that of nicardipine.
    Sugiyama A, Satoh Y, Takahara A, Ando K, Nakamura Y, Hashimoto K.
    Heart Vessels; 2005 May 15; 20(3):112-5. PubMed ID: 15912307
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of a dual L/N-type Ca(2+) channel blocker cilnidipine in the rat focal brain ischemia model.
    Takahara A, Konda T, Enomoto A, Kondo N.
    Biol Pharm Bull; 2004 Sep 15; 27(9):1388-91. PubMed ID: 15340224
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats.
    Hosono M, Hiruma T, Watanabe K, Hayashi Y, Ohnishi H, Takata Y, Kato H.
    Jpn J Pharmacol; 1995 Oct 15; 69(2):119-25. PubMed ID: 8569048
    [Abstract] [Full Text] [Related]

  • 11. Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles.
    Konno Y, Kimura K.
    Int Heart J; 2008 Nov 15; 49(6):723-32. PubMed ID: 19075488
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of a dual L/N-type Ca(2+) channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs.
    Konda T, Takahara A, Maeda K, Dohmoto H, Yoshimoto R.
    Eur J Pharmacol; 2001 Feb 09; 413(1):117-20. PubMed ID: 11173070
    [Abstract] [Full Text] [Related]

  • 16. Antianginal effects of lercanidipine on the vasopressin or methacholine induced anginal model in rats.
    Sasaki T, Maruyama H, Kase Y, Takeda S, Aburada M.
    Biol Pharm Bull; 2005 May 09; 28(5):811-6. PubMed ID: 15863884
    [Abstract] [Full Text] [Related]

  • 17. [Effect of palonidipine hydrochloride (TC-81), a new dihydropyridine derivative, on various myocardial ischemic models].
    Kishimoto T, Okamiya Y, Aoki K, Ota M, Hoshina K, Takeshita T.
    Nihon Yakurigaku Zasshi; 1993 Aug 09; 102(2):85-100. PubMed ID: 8370558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T, Asano M, Shiono K, Shibasaki M, Inagaki O.
    Br J Clin Pharmacol; 1985 Aug 09; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [Abstract] [Full Text] [Related]

  • 20. Antianginal effects of YM-16151-4 in various experimental angina models.
    Uchida W, Shibasaki K, Asano M, Takenaka T.
    J Cardiovasc Pharmacol; 1993 May 09; 21(5):701-8. PubMed ID: 7685438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.